An estimated 475,000 lives were saved in England and Scotland, but the inquiry says a lower vaccine uptake among some groups ...

The U.S. helped pioneer the technology, but new funding cuts may shift breakthroughs — and industry leadership — overseas.

Hospitals filled to capacity. Case counts climbing by the hour. Quarantine became routine. It was the beginning of the ...

Jan 20 (Reuters) - Novavax ‌said on Tuesday it signed a licensing ‌agreement allowing Pfizer access to its technology that boosts immune responses to vaccines for use in up to two infectious diseases, ...

New vaccine momentum reflects growing urgency of avian influenza (H5N1) threat and reinforces need for coordinated global ...

The people who research, make and invest in vaccines are nervous. Some companies have started pulling back on their vaccine ...

It might seem surprising that, as a Japanese researcher, Eizo Takashima became captivated by malaria, when his home country rid itself of the disease in the last century. But, after a love of science ...

USDA Secretary Brooke Rollins says a vaccine for avian influenza isn’t quite ready for widespread use, but progress is being ...

On 12 April 1955, Dr Jonas Salk announced that his vaccine was safe and effective – but he refused to profit from it.